References
- Forsyth W.G.C., Roberts J.B. Cacao polyphenolic substances 5. The structure of cacao leucocianidin. Biochemical Journal 1960; 74: 374–378
- Kim H., Keeney P.G. (-)-Epicatechin content in fermented and unfermented cocoa beans. Journal of Food Science 1984; 49: 1090–1091
- Porter L.J, Ma Z., Chan B.G. Cacao procyanidins; Major flavonoid identification of some minor metabolites. Phytochemistry 1991; 30: 1657–1663
- Osakabe N., Yamagishi M., Sanbongi C., Natsume M., Takizawa T., Osawa T. The antioxidative substances in cacao liquor. Journal of Nutritional Science and Vitaminology 1998; 44: 313–321
- Sanbongi C., Osakabe N., Natsume M., Takizawa T., Gomi S., Osawa T. Antioxidative polyphenols isolated from Theobroma cacao. Journal of Agricultural and Food Chemistry 1998; 46: 454–457
- Hamerstone J.F., Lazarus S.A., Mitchell A.E., Rucker R., Schmitz H.H. Identification of procyanidins in cocoa (Theobroma cacao) and chocolate using high-performance liquid chromatography/mass. Journal of Agricultural and Food Chemistry 1999; 47: 490–496
- Long L.H., Lan A.N.B., Hsuan F.T.Y., Halliwell B. Generation of hydrogen peroxide by “antioxidant” beverages and the effect of milk addition. Is cocoa the best beverage?. Free Radical Research 1999; 31: 67–71
- Hertog M.G.L., Feskens E.J.M., Hollman P.C.H., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342: 1007–1011
- Hertog M.G.L., Feskens E.J.M., Kromhout D. Antioxidant flavonols and coronary heart disease risk. Lancet 1997; 349: 699–699
- Knekt P., Jarvinen R., Reunanen A., Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. British Medical Journal 1996; 312: 478–481
- Tijburg L.B., Wiseman S.A., Mejier G.W., Westsrate J.A. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolemic rabbits. Atherosclerosis 1997; 135: 37–47
- Yamakoshi J., Kataoka S., Koga T., Ariga T. Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 1999; 142: 139–149
- Kondo K., Hirano R., Matsumoto A., Igarashi O., Itakura H. Inhibition of LDL oxidation by cocoa. Lancet 1996; 348: 1514–1514
- Price M.L., Butler L.G. Rapid visual estimation and spectrophotometric determination of tannin content of sorghum grain. Journal of Agricultural Food Chemistry 1977; 25: 1268–1273
- Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring in vitro oxidation of human low density lipoprotein. Free Radical Research Communications 1989; 6: 67–75
- Hirano R., Kondo K., Iwamoto T., Igarashi O., Itakura H. Effect of antioxidants on oxidative susceptibility of low-density lipoprotein. Journal of Nutritional Science and Vitaminology 1997; 43: 435–444
- Chung B.H., Segrest J.P., Ray M.J., Brunzell J.D., Hokanson J.E., Krauss R.M., Beaudrie K., Cone J.T. Single vertical spin gradient ultracentrifugation. Methods in Enzymology 1986; 128: 181–209
- Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Analytical Biochemistry 1985; 150: 76–85
- Piskura M., Terao J. Accumulation of (-) epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. Journal of Nutrition 1998; 128: 1172–1178
- Lotito S.B., Fraga C.G. (+)-Catechin prevents human plasma oxidation. Free Radical Biology and Medicine 1998; 24: 435–441
- Speek A.J., Schrijver J., Schreurs W.H.P. Fluorometric determination of total vitamin C in whole blood by high-performance liquid chromatography with pre-column derivatization. Journal of Chromatography 1984; 305: 53–60
- Steinberg D., Parthasarathy S., Carew T.E., Witztim J.L. Beyond cholesterol; Modification of low-density lipoprotein that increase its atherogenesity. New England Journal of Medicine 1989; 320: 915–924
- Halliwell B. Oxidation of low-density lipoproteins; Question of initiation, propagation, and the effect of antioxidants. American Journal of Clinical Nutrition 1995; 61: 670–677
- Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 393–795
- Hoffman R.M., Garewal H.S. Antioxidants and prevention of coronary heart disease. Archives of Internal Medicine 1995; 155: 241–246
- Duell P.B. The role of dietary antioxidants in prevention of atherosclerosis. Endocrinologist 1995; 5: 347–356
- Renoud S., de Lorgeril M. Wine alcohol, platelets, and French paradox for coronary heart disease. Lancet 1992; 339: 1523–1526
- Frankel E.N., Kanner J., German J.B., Parks E., Kineslla J.E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454–457
- Kondo K., Matsumoto A., Kurata H., Tanahashi H., Koda H., Amachi T., Itakura H. Inhibition of oxidation of low-density lipoprotein with red wine. Lancet 1994; 344: 1152–1152
- Baba S., Osakabe N., Yasuda A., Natsume M., Takizawa T., Nakamura T., Terao J. Bioavailability of (-)-epicatechin upon intake of chocolate and cocoa in human volunteers. Free Radical Research, in press
- Furman B., Lavy A., Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. American Journal of Clinical Nutrition 1995; 61: 549–554
- Nigdikar S.V., Williams N.R., Griffin B.A., Howard A.N. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. American Journal of Clinical Nutrition 1998; 68: 258–265